Patents Represented by Attorney Seed Intellectual Property Law Firm PLLC
  • Patent number: 7531320
    Abstract: The present invention provides compounds and methods for modulating transcription activated by ?-catenin/TCF, such as the selective inhibition of genes targeted by the Wnt/?-catenin pathway.
    Type: Grant
    Filed: August 27, 2004
    Date of Patent: May 12, 2009
    Assignee: Choongwae Pharma Corporation
    Inventors: Michael Kahn, SeWoong Oh, DaeHoon Kim, JongRyul Ha, Katayoon Hojjati-Emami